PT Metro Healthcare Indonesia Tbk (CARE.JK)
IDR 197.0
(0.0%)
IDR 197.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 242.68 Billion | 233.97 Billion | 290.93 Billion | 216.29 Billion | 154.07 Billion | 87.2 Billion |
| Cost of Revenue | 153.02 Billion | 137.73 Billion | 145 Billion | 113.4 Billion | 78.41 Billion | 49.55 Billion |
| Gross Profit | 89.65 Billion | 96.23 Billion | 145.93 Billion | 102.89 Billion | 75.66 Billion | 37.65 Billion |
| Operating Expenses | 125.19 Billion | 156.82 Billion | 131.83 Billion | 118.75 Billion | 66.98 Billion | 41.13 Billion |
| Selling, General and Administrative Expenses | 125.19 Billion | 15.55 Billion | 33.35 Billion | 23.18 Billion | 12.56 Billion | 8.14 Billion |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 141.26 Billion | 98.48 Billion | 95.57 Billion | 54.42 Billion | -1.82 Billion |
| Cost and Expenses | 278.81 Billion | 294.56 Billion | 276.83 Billion | 232.15 Billion | 145.4 Billion | 90.68 Billion |
| Operating Income | -36.13 Billion | -60.59 Billion | 14.09 Billion | -15.86 Billion | 8.67 Billion | -3.48 Billion |
| Interest Expense | 76.85 Billion | 89.33 Billion | 25.43 Billion | 11.3 Billion | 19.24 Billion | 23.16 Billion |
| Income Tax Expense | 4.56 Billion | 288.46 Million | 332.91 Million | -375.14 Million | 2.76 Billion | 1.8 Billion |
| Earnings before Tax | -106.12 Billion | -93.31 Billion | 6.5 Billion | 13.79 Billion | -21.52 Billion | -26.05 Billion |
| Net Income | -110.91 Billion | -93.6 Billion | 6.09 Billion | 14.31 Billion | -24.28 Billion | -27.48 Billion |
| Earnings Per Share Basic | -3.34 | -2.82 | 0.18 | 0.43 | -0.73 | -0.83 |
| Earnings Per Share Diluted | -3.34 | -2.82 | 0.18 | 0.43 | -0.73 | -0.83 |
| Weighted Average Shares Outstanding | 33.25 Billion | 33.25 Billion | 33.25 Billion | 33.25 Billion | 33.25 Billion | 33.25 Billion |
| Weighted Average Shares Outstanding (Diluted) | 33.25 Billion | 33.25 Billion | 33.25 Billion | 33.25 Billion | 33.25 Billion | 33.25 Billion |
| Gross Margin | 0.37 | 0.41 | 0.50 | 0.48 | 0.49 | 0.43 |
| EBIT Margin | -0.03 | -0.13 | 0.10 | 0.12 | 0.07 | -0.03 |
| Profit Margin | -0.46 | -0.40 | 0.02 | 0.07 | -0.16 | -0.32 |
| EBITDA | -7.68 Billion | 19.7 Billion | 31.39 Billion | 37.21 Billion | 5.83 Billion | 4.2 Billion |
| Earnings Before Tax Margin | -0.15 | -0.26 | 0.05 | -0.07 | 0.06 | -0.04 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 72.93 Billion | 84.56 Billion | 80.88 Billion | 90.29 Billion | 242.68 Billion | 57.2 Billion |
| Cost of Revenue | 51.21 Billion | 60.62 Billion | 52.49 Billion | 63.52 Billion | 153.02 Billion | 42.9 Billion |
| Gross Profit | 21.71 Billion | 23.94 Billion | 28.38 Billion | 26.77 Billion | 89.65 Billion | 14.3 Billion |
| Operating Expenses | 33.98 Billion | 31.41 Billion | 32.03 Billion | 30.64 Billion | 125.19 Billion | 38.8 Billion |
| Selling, General and Administrative Expenses | 33.98 Billion | 31.41 Billion | 32.03 Billion | 30.64 Billion | - | -8.99 Billion |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 1.4 Billion | 136.79 Million | -648.01 Million | 178.32 Million | 229.1 Million |
| Cost and Expenses | 85.19 Billion | 92.04 Billion | 84.53 Billion | 94.16 Billion | 278.22 Billion | 81.7 Billion |
| Operating Income | -12.26 Billion | -7.47 Billion | -3.65 Billion | -3.87 Billion | -35.53 Billion | -38.83 Billion |
| Interest Expense | 20.54 Billion | 17.77 Billion | 18.42 Billion | 13.42 Billion | 75.77 Billion | 26.96 Billion |
| Income Tax Expense | 827.61 Million | 373.28 Million | 1.21 Billion | 2.77 Billion | 4.56 Billion | 904.44 Million |
| Earnings before Tax | -23.16 Billion | -22.84 Billion | -20.81 Billion | -17.11 Billion | -106.12 Billion | -49.82 Billion |
| Net Income | -24.02 Billion | -23.27 Billion | -22.1 Billion | -19.98 Billion | -110.91 Billion | -50.79 Billion |
| Earnings Per Share Basic | -0.72 | -0.70 | -0.66 | -0.60 | - | -1.53 |
| Earnings Per Share Diluted | -0.72 | -0.70 | -0.66 | -0.60 | - | -1.53 |
| Weighted Average Shares Outstanding | 33.25 Billion | 33.25 Billion | 33.25 Billion | 33.25 Billion | 33.25 Billion | 33.25 Billion |
| Weighted Average Shares Outstanding (Diluted) | 33.25 Billion | 33.25 Billion | 33.25 Billion | 33.25 Billion | 33.25 Billion | 33.25 Billion |
| Gross Margin | 0.30 | 0.28 | 0.35 | 0.30 | 0.37 | 0.25 |
| EBIT Margin | -0.04 | -0.01 | 0.02 | 0.02 | - | -0.40 |
| Profit Margin | -0.33 | -0.28 | -0.27 | -0.22 | -0.46 | -0.89 |
| EBITDA | -2.62 Billion | -1.26 Billion | 1.8 Billion | 1.49 Billion | - | -22.85 Billion |
| Earnings Before Tax Margin | -0.17 | -0.09 | -0.05 | -0.04 | -0.15 | -0.68 |
0026
RANA
AONNF
RIPLEY
INDSWFTLAB
PAZA